Home Medicine Propylthiouracil Associated Antineutrophil Cytoplasmic Antibodies (ANCA) in Patients with Childhood Onset Graves' Disease
Article
Licensed
Unlicensed Requires Authentication

Propylthiouracil Associated Antineutrophil Cytoplasmic Antibodies (ANCA) in Patients with Childhood Onset Graves' Disease

  • EMAIL logo , , , and
Published/Copyright: October 22, 2020

Abstract

Propylthiouracil (PTU) can induce anti-myeloperoxidase (MPO-ANCA) positive vasculitis. We performed a cross-sectional study to estimate the prevalence of MPO-ANCA in patients with childhood onset Graves' disease (GD) receiving PTU and to assess the relationship between ANCA and clinical manifestations of vasculitis. We studied 60 patients (59 girls and one boy) between 7.3 and 25.0 years of age (mean ± SD, 14.71 ± 4.49). GD, diagnosed at the age of 3.0 to 14.5 years (11.3 ± 2.48), was designated as: newly diagnosed, on PTU therapy, and after PTU discontinuation in 4, 50 and 6 patients, respectively. Manifestations of vasculitis were noted and the patients were tested for MPOANCA, antinuclear antibodies, blood urea nitrogen, creatinine and urine analysis. Twentysix patients (43.3%) reacted positively for MPOANCA, 23 were on PTU therapy (0.42 to 6.00, median 3.00 years) and three had discontinued PTU. There were 34 (56.7%) ANCA-negative patients and 27 patients on PTU therapy (0.25 to 5.17, median 1.00 years, p = 0.012). Vasculitis presented in 16 patients (26.7%), all of whom were receiving PTU at the time of the study. The percentage of vasculitis among MPO-ANCA positive patients was 27.6% more than in the negative group, p = 0.017. PTU was discontinued in patients with vasculitis and positive for MPO-ANCA. Our findings show a high prevalence of MPO-ANCA positivity and a significantly higher percentage of vasculitis among these patients, suggesting that patients taking PTU should be closely observed for the appearance of MPOANCA and signs of vasculitis, especially patients GD who have been treated for a long time.

Published Online: 2020-10-22
Published in Print: 2008-06-01

© 2020 by Walter de Gruyter Berlin/Boston

Articles in the same Issue

  1. TITLE
  2. TABLE OF CONTENTS
  3. EDITORIAL. Why the Consensus for Consensus?
  4. REVIEW. Translating Transition: A Critical Review of the Diabetes Literature
  5. SOCIETY NEWS. VanWyk Award Acceptance Speech, May 5, 2008
  6. IMAGES IN PEDIATRIC ENDOCRINOLOGY. Pseudopuberty and Juvenile Hypothyroidism
  7. ORIGINAL CONTRIBUTIONS
  8. Long-term Follow-up of Patients with Congenital Hyperinsulinism in Austria
  9. An Analysis of Predictive Factors for the Conversion from Premature Thelarche into Complete Central Precocious Puberty
  10. Propylthiouracil Associated Antineutrophil Cytoplasmic Antibodies (ANCA) in Patients with Childhood Onset Graves' Disease
  11. Molecular Analysis of the AR and SRD5A2 Genes in Patients with 46,XY Disorders of Sex Development
  12. Efficacy and Safety of Inhaled Human Insulin (Exu hera®) Compared to Subcutaneous Insulin in Children Ages 6 to 11 Years with Type 1 Diabetes Mellitus: Results of a 3-Month, Randomized, Parallel Trial
  13. Usefulness of Growth Hormone (GH) Stimulation Tests and IGF-1 Concentration Measurement in GH Deficiency Diagnosis
  14. Hyperglycemia and Hypoinsulinemia in Patients with Fanconi-Bickel Syndrome
  15. PATIENT REPORT LETTERS
  16. Glycogen Storage Disease Type Ilia Presenting as Non-Ketotic Hypoglycemia: Use of a Newly Approved Commercially Available Mutation Analysis to Non-Invasively Confirm the Diagnosis
  17. Clinical and Laboratory Findings of Two Newborns with Wiedemann-Rautenstrauch Syndrome: Additional Features, Evaluation of Bone Turnover and Review of the Literature
  18. Congenital Nephrotic Syndrome and Persistent Hypothyroidism After Bilateral Nephrectomy
  19. LETTER TO THE EDITOR
  20. Re: Relationship between endothelial dysfunction, carotid artery intima media thickness and circulating markers of vascular inflammation in obese hypertensive children and adolescents (J Pediatr Endocrinol Metab 2007; 20: 1125-1136)
  21. The Incidence of Glucose Disorders Related to Cystic Fibrosis Could Be Higher with Current Criteria (Re: Carbohydrate Metabolism Changes in Cystic Fibrosis. J Pediatr Endocrinol Metab 2007; 20: 621-663)
  22. CALENDAR
Downloaded on 24.3.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2008-210608/html
Scroll to top button